We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$20.7M
Cap. Flow
+$5.39M
Cap. Flow %
1.83%
Top 10 Hldgs %
28.09%
Holding
92
New
25
Increased
25
Reduced
19
Closed
18

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$4.59M
2
ZTS icon
Zoetis
ZTS
+$4.07M
3
TMO icon
Thermo Fisher Scientific
TMO
+$3.62M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.97M
5
SYK icon
Stryker
SYK
+$2.87M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.28M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.79M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.91M
4
MRK icon
Merck
MRK
+$4.77M
5
CAH icon
Cardinal Health
CAH
+$3.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.68%
2 Financials 2.98%
3 Energy 1.23%
4 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
51
Bio-Rad Laboratories Class A
BIO
$9.48B
$2.22M 0.76%
+10,000
New +$2.25M
PRGO icon
52
Perrigo
PRGO
$1.75B
$2.12M 0.72%
25,000
-20,000
-44% -$1.56M
LH icon
53
Labcorp
LH
$26.1B
$2.1M 0.71%
+16,180
New +$2.16M
XRAY icon
54
Dentsply Sirona
XRAY
$2.32B
$2.09M 0.71%
+35,000
New +$2.08M
MTD icon
55
Mettler-Toledo International
MTD
$28.6B
$2M 0.68%
+3,200
New +$1.92M
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$1.9M 0.65%
+30,000
New +$1.86M
QGEN icon
57
Qiagen
QGEN
$9.05B
$1.89M 0.64%
+56,583
New +$1.95M
DGX icon
58
Quest Diagnostics
DGX
$26.2B
$1.87M 0.64%
+20,000
New +$2.12M
NBIX icon
59
Neurocrine Biosciences
NBIX
$16.8B
$1.84M 0.63%
30,000
+10,000
+50% +$528K
RDY icon
60
Dr. Reddy's Laboratories
RDY
$10.1B
$1.78M 0.61%
+250,000
New +$1.8M
TEVA icon
61
Teva Pharmaceuticals
TEVA
$42.1B
$1.76M 0.6%
+100,000
New +$2.25M
CTLT
62
DELISTED
CATALENT, INC.
CTLT
$1.65M 0.56%
+41,400
New +$1.53M
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
$1.63M 0.56%
30,000
+5,000
+20% +$256K
ATHN
64
DELISTED
Athenahealth, Inc.
ATHN
$1.49M 0.51%
+12,000
New +$1.65M
BRKR icon
65
Bruker
BRKR
$8.58B
$1.49M 0.51%
+50,000
New +$1.44M
KITE
66
DELISTED
Kite Pharma, Inc.
KITE
$1.44M 0.49%
8,000
-10,000
-56% -$1.39M
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.35M 0.46%
25,000
-5,000
-17% -$294K
CBM
68
DELISTED
Cambrex Corporation
CBM
$1.32M 0.45%
+24,039
New +$1.32M
TSRO
69
DELISTED
TESARO, Inc.
TSRO
$1.29M 0.44%
10,000
-5,000
-33% -$621K
KND
70
DELISTED
Kindred Healthcare
KND
$177K 0.06%
25,963
-99,037
-79% -$843K
ACHC icon
71
Acadia Healthcare
ACHC
$2.96B
– –
-50,000
Closed -$2.47M
ASRT
72
DELISTED
Assertio
ASRT
– –
-3,000
Closed -$1.93M
CAH icon
73
Cardinal Health
CAH
$55.5B
– –
-50,000
Closed -$3.9M
CYH icon
74
Community Health Systems
CYH
$415M
– –
-220,000
Closed -$2.19M
GMED icon
75
Globus Medical
GMED
$11.6B
– –
-77,340
Closed -$2.56M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q3 2017 Portfolio in Review

As of Q3 2017, Sivik Global Healthcare held 92 positions worth $294M, up 7.6% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare's Q3 2017 filing shows 25 new, 25 increased, 19 reduced and 18 closed positions. Its largest new stake was Danaher: 62,040 shares worth $4.72M. The largest sale was Johnson & Johnson, an estimated $9.28M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

  • Sivik Global Healthcare's largest Q3 2017 buy was Danaher: 62,040 shares worth $4.72M.
  • Sivik Global Healthcare added most to Thermo Fisher Scientific in Q3 2017, an estimated $3.62M increase.
  • Sivik Global Healthcare's biggest Q3 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $6.79M.
  • Sivik Global Healthcare fully exited Johnson & Johnson in Q3 2017, selling an estimated $9.28M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $294M portfolio in Q3 2017.
  • Sivik Global Healthcare opened 25 new positions and closed 18 in Q3 2017.
  • Sivik Global Healthcare's portfolio value rose 7.6% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q3 2017, filed 8 Nov 2017.